STERIS (STE)
(Delayed Data from NYSE)
$236.98 USD
-2.48 (-1.04%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $236.78 -0.20 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
- YR Estimate
- 03/31/2024
- 03/31/2023
- 03/31/2022
- 03/31/2021
- 03/31/2020
- Revenue - Line of Business (LOBR)
- Revenues: Healthcare
- 3,613.02
- 3,085.13
- 2,845.47
- 1,954.06
- 1,423.20
- Revenue - Line of Business (LOBR)
- Revenues: Applied Sterilization Technologies
- 953.98
- 914.43
- 852.97
- 685.91
- 627.15
- Revenue - Line of Business (LOBR)
- Revenues: Life Sciences
- 571.70
- 536.70
- 524.96
- 467.55
- 416.94
- Revenue - Line of Business (LOBR)
- Revenues: Healthcare Products: Consumables
- 1,248.42
- 1,050.32
- 1,004.61
- 510.95
- 486.43
- Revenue - Line of Business (LOBR)
- Revenues: Healthcare Products: Service
- 1,273.06
- 1,138.23
- 1,058.36
- 854.25
- 882.67
- Revenue - Line of Business (LOBR)
- Revenues: Healthcare Products: Capital equipment
- 1,091.54
- 896.59
- 782.51
- 588.86
- 617.71
- Revenue - Line of Business (LOBR)
- Revenues: Life Sciences: Consumables
- 251.58
- 241.11
- 239.37
- 215.01
- 185.90
- Revenue - Line of Business (LOBR)
- Revenues: Life Sciences: Capital equipment
- 155.52
- 147.42
- 142.28
- 128.36
- 112.75
- Revenue - Line of Business (LOBR)
- Revenues: Life Sciences: Service
- 164.60
- 148.17
- 143.32
- 124.19
- 118.29
- Revenue - Geographic (GEOR)
- Geographic Revenue: United States
- 3,751.44
- 3,586.49
- 2,943.95
- 2,227.04
- 2,211.72
- Revenue - Geographic (GEOR)
- Geographic Revenue: Other Foreign Revenues
- 1,304.57
- 1,296.89
- 1,197.59
- 808.58
- 755.35
- Revenue - Geographic (GEOR)
- Geographic Revenue: Ireland
- 82.70
- 74.46
- 81.86
- 71.91
- 63.82
- Income - Line of Business (LOBI)
- Operating income / (loss): Healthcare
- 871.36
- 706.02
- 626.10
- 427.09
- 356.42
- Income - Line of Business (LOBI)
- Operating income / (loss): Applied Sterilization Technologies
- 439.74
- 429.02
- 410.10
- 310.65
- 270.92
- Income - Line of Business (LOBI)
- Operating income / (loss): Corporate and Other
- -348.50
- -264.79
- -260.06
- -219.15
- -207.02
- Income - Line of Business (LOBI)
- Operating income / (loss): Life Sciences
- 221.35
- 210.23
- 216.19
- 180.80
- 144.09